Back
TG Therapeutics 10K Form
Buy
63
TGTX
TG Therapeutics
Last Price:
$35.48
Seasonality Move:
2.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TGTX News And Ratings
See the #1 stock for the next 7 days that we like better than TGTX
TGTX Financial Statistics
Sales & Book Value
| Annual Sales: | $329M |
|---|---|
| Cash Flow: | $-28.7M |
| Price / Cash Flow: | 53.48 |
| Annual Sales: | $1.50 |
| Price / Book: | 23.4 |
Profitability
| EPS (TTM): | 0.24000 |
|---|---|
| Net Income (TTM): | $39.2M |
| Gross Margin: | $290.5M |
| Return on Equity: | 19.78% |
| Return on Assets: | 7.54% |
TG Therapeutics Earnings Forecast
Key TG Therapeutics Financial Ratios
-
The Gross Profit Margin over the past 29 years for TGTX is 88.30%.
-
The Selling, General & Administrative Expenses for TGTX have been equal to 46.90% of Gross Profit Margin.
-
The Research & Development expenses have been 28.66% of Revenue.
-
The Interest Expense is 102.76% of Operating Income.
-
The Net Earning history of TGTX is 7.11% of Total Revenues.
-
Per Share Earnings over the last 29 years have been positive in 15 years.
TG Therapeutics Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TGTX |
| CUSIP: | 88322Q |
| Website: | tgtherapeutics.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 4.02 |
| Quick Ratio: | 2.01 |
Price-to-Earnings
| Trailing P/E Ratio: | 233.2 |
|---|---|
| Forward P/E Ratio: | 19.42 |
TGTX Technical Analysis vs Fundamental Analysis
Buy
63
TG Therapeutics (TGTX)
is a Buy
Is TG Therapeutics a Buy or a Sell?
-
TG Therapeutics stock is rated a BuyThe current TG Therapeutics [TGTX] share price is $34.98. The Score for TGTX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.